Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Investigational Facial Serum #2
- Development stage
- Preclinical
- Lead developer
- Victoria Collotta
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Investigational Facial Serum #2 is a topical preparation designed to improve the signs of aging. It contains an unspecified active comparator and is currently undergoing clinical evaluation to assess its efficacy in addressing facial fine lines and wrinkles, including crow's feet. The product is being developed under the sponsorship of Victoria Collotta.
Beyond the preview
Go deeper on Investigational Facial Serum #2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Investigational Facial Serum #2.